Indicators

Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 8 Next >

Why Is BioMarin Stock Trading Higher On Thursday?

February 20, 2025

BioMarin: EPS Surges Past Expectations

February 19, 2025

Earnings Scheduled For February 19, 2025

February 19, 2025

Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?

February 13, 2025

10 Health Care Stocks With Whale Alerts In Today's Session

February 12, 2025

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

January 19, 2025

Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators

January 08, 2025

10 Magnificent Stocks That Can Make You Richer in 2025

January 03, 2025

The Latest Analyst Ratings For Biomarin Pharmaceutical

December 12, 2024

The Analyst Landscape: 29 Takes On Biomarin Pharmaceutical

November 15, 2024

Peering Into Biomarin Pharmaceutical's Recent Short Interest

November 06, 2024

CAMP4 Analyst Highlights Rare Disease Platform Potential

November 05, 2024

BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth

October 30, 2024

In-Depth Examination Of 29 Analyst Recommendations For Biomarin Pharmaceutical

October 30, 2024

A Look Ahead: Biomarin Pharmaceutical's Earnings Forecast

October 28, 2024

How Is The Market Feeling About Biomarin Pharmaceutical?

October 15, 2024

Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients

October 09, 2024

Analyst Expectations For Biomarin Pharmaceutical's Future

October 04, 2024

BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish

September 25, 2024

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $14,000 Today

September 23, 2024

Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

September 22, 2024

GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday

September 17, 2024

Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term

September 16, 2024

(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest

September 10, 2024

FDA Battles Backlog of Drug Factory Inspections Since COVID-19

September 06, 2024

BioMarin Restructures, Outlines Roadmap To $4B Revenues By 2027

September 05, 2024

Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (14 Ratings)

September 05, 2024

Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In

September 04, 2024

(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest

August 21, 2024

Beyond The Numbers: 11 Analysts Discuss Biomarin Pharmaceutical Stock

August 20, 2024

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.